Tablet

SLU-PP-332 is a research-only synthetic pan–estrogen-related receptor (ERR) agonist designed to support studies of mitochondrial biogenesis, cellular respiration, and energy metabolism. By activating ERRα, ERRβ, and ERRγ pathways, it provides researchers with a focused tool for investigating metabolic and aerobic-exercise–related signaling. Supplied as high-purity oral capsules with defined microgram dosing, SLU-PP-332 enables consistent handling and repeatable experimental conditions. It is intended strictly for scientific research and laboratory investigation and is not approved for human or veterinary use.